about
Immunological features of the non-structural proteins of porcine reproductive and respiratory syndrome virusDisease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza virusesRIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus InfectionPoly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.Intranasal administration of dsRNA analog poly(I:C) induces interferon-α receptor-dependent accumulation of antigen experienced T cells in the airways.STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients.Interferon-α suppresses invasion and enhances cisplatin-mediated apoptosis and autophagy in human osteosarcoma cells.The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophagesIFN-α/β receptor signaling promotes regulatory T cell development and function under stress conditions.The p60 and NamA autolysins from Listeria monocytogenes contribute to host colonization and induction of protective memory.Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell ActivationThe TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction.Synthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation.STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria.Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity.The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I InterferonsPrevention of SHIV transmission by topical IFN-β treatment.Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2V617F allelic burden.Fueling autoimmunity: type I interferon in autoimmune diseases.ELF4 is critical for induction of type I interferon and the host antiviral response.Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway.Type I Interferons as Regulators of Lung Inflammation.The interferons and their receptors--distribution and regulation.Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1.Type I interferons as regulators of human antigen presenting cell functions.Vaccine adjuvant uses of poly-IC and derivatives.Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota.Functions of invariant NK T cells are modulated by TLR ligands and IFN-α.Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm.Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease.Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-β response to viral infection.Abrogation of the interferon response promotes more efficient human cytomegalovirus replication.Type I Interferon Is a Catastrophic Feature of the Diabetic Islet MicroenvironmentWhole blood stimulation with Toll-like receptor (TLR)-7/8 and TLR-9 agonists induces interleukin-12p40 expression in plasmacytoid dendritic cells in rhesus macaques but not in humans.Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.Defining the distinct, intrinsic properties of the novel type I interferon, epsilon.Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.Overview. Type I interferons as primers, activators and inhibitors of innate and adaptive immune responses.Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.
P2860
Q27006825-35E0AC6C-0F7D-4C68-9C66-01C573D72CA9Q30363295-82E9A357-EEFA-4095-BF1E-347C1D7D5F31Q30390782-78E1A4FE-5738-46D7-A00B-9C1A7EA87ED6Q34262302-96D772ED-2257-4445-8381-313EA8565D0AQ34510913-FFF1EBF2-6C97-4700-A5A9-7675D24D0D0CQ34931400-CA17374B-606D-4FD4-A18C-E24F6958D6A2Q35094178-240BF67B-6DA8-46DC-8669-3AEF6552F41EQ35154923-471E7A07-49F7-4728-B016-20D31CFCBB4DQ35472250-E18EE0E5-7FD4-4B45-A2D5-48D9AB76FFE9Q35688162-8FEB3ABD-BFDC-4B0D-AA18-7D5335BDEBAFQ35864559-B08FEA7F-94EE-4259-A34A-1745DB460A37Q35885464-20C924B9-5C98-4687-8B12-3C7372C2B349Q35895331-40F81A4E-FCC3-42B5-8648-C9A9DBF86A10Q36177240-C1090AAE-AE06-4FDE-B282-D6BDEE9C7A2FQ36221861-2CDD83D9-4E96-4DC7-A646-C2BC81768BCEQ36857386-0D34ACE6-8052-4110-83B6-671598AB37E0Q37150111-BA98A007-2C0C-47BB-8F60-8F1ECF47BE21Q37286731-221C8A02-6AEB-4DC6-9A19-88271849ADFAQ37416120-D2661541-E2EF-46A3-A94E-9C87DCDF3EB6Q37612596-99D1240B-1C1E-4163-BF5E-8DE3F5B1485EQ37672450-C1B2DFBD-7320-4A42-AA73-35B959BB3918Q37691992-F1B7FECA-F34A-4C51-A0CB-017DAD112C07Q37992849-3CF270AD-F49C-465F-BE54-CE8C638BC8DFQ38181142-ADFBFD50-1BA3-4F7B-A58B-666C82CCEC66Q38215320-E5737116-5485-42FE-AC14-BB497F393825Q38259510-A27ADF0F-46A7-45EB-ADD6-21731EEC19F2Q38744710-4D7A2421-D0B9-448B-968E-62B17794F141Q38984210-A59F694D-3A60-4CFF-9564-83320B736AC7Q39292313-D6BFE99B-8455-450E-8952-310768004D57Q39389626-0A48590D-CC5E-4C1F-B7F7-14BB16B7CC18Q39739400-FCB17656-3780-4A4C-A73E-357904FB05D3Q41491260-389BB7B3-4768-4E5F-9B82-807061EB3757Q41665315-86033FDD-E6BA-49D2-8EC1-41EBE62022C6Q41672962-65315B6F-BCE5-4628-A153-DFB5D9BEA9E9Q42259626-ACA0D835-7590-486F-8EA0-462E83D1E0DDQ45066620-BFCD3EE9-C51A-4872-BA70-F2025704324FQ46251732-0D9F3434-EEE7-464B-82E8-F86DA0823561Q47983897-21BD9304-3560-42FF-9F55-288B54F51AE0Q48291382-9841948F-8FB4-4CCC-8B1D-5FCC3E4FD23BQ50098055-8AE47664-2D5E-4142-82D5-5A76857E54BE
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modulation of T-cell function by type I interferon.
@en
Modulation of T-cell function by type I interferon.
@nl
type
label
Modulation of T-cell function by type I interferon.
@en
Modulation of T-cell function by type I interferon.
@nl
prefLabel
Modulation of T-cell function by type I interferon.
@en
Modulation of T-cell function by type I interferon.
@nl
P2860
P356
P1476
Modulation of T-cell function by type I interferon.
@en
P2093
David F Tough
P2860
P2888
P304
P356
10.1038/ICB.2012.7
P577
2012-03-06T00:00:00Z
P6179
1051056796